Carlisle Companies Incorporated (CSL) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Carlisle Companies Incorporated  (NYSE: CSL)
 

Carlisle Companies Incorporated Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Carlisle Companies Incorporated inventory turnover ratio, the Carlisle Companies Incorporated's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 6.94 in the second quarter 2026, CSL's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Carlisle Companies Incorporated in Jun 30 2026 quarter, has decreased to 53 days, compare to 54 days, in the Mar 31 2026 quarter.

Within Healthcare sector 54 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 474 in the first quarter 2026, to 587.

CSL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Carlisle Companies Incorporated Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CSL Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -1.64 % -9.18 % -5.37 % 4.11 % 17.5 %
Y / Y Cost of Sales Growth 10.29 % -2.99 % 4.14 % 5.19 % 3.03 %
Inventory Turnover Ratio (TTM) 6.94 6.71 6.59 6.44 6.42
CSL's Total Ranking # 587 # 474 # 140 # 150 # 165
Average inventory processing period 53 54 55 57 57
Seq. Inventory Growth 2.43 % 7.53 % -7.08 % -3.89 % -5.42 %
Seq. Cost of Sales Growth 45.43 % -7.79 % -13.3 % -5.14 % 27.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 19
Healthcare Sector # 55
Overall Market # 587

Inventory Turnover Ratio Statistics
High Average Low
7.79 6.07 3.86
(Jun 30 2024)   (Sep 30 2012)



CSL Company Profile >> Back to CSL Efficiency Comparisons >> Compare CSL Inventory Turnover Ratio to its Competitors

Financial Statements
Carlisle Companies Incorporated's Inventories $ 493 Millions Visit CSL's Balance sheet
Carlisle Companies Incorporated's Cost of Revenues TTM $ 3,300 Millions Visit CSL's Income Statement
What are CSL's Sales? Visit CSL's Sales by Segment

Other Inventory Turnover Ratios
Carlisle Companies Incorporated's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CSL's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CSL's Competitors
Inventory Turnover Ratio for CSL's Suppliers
Inventory Turnover Ratio for CSL's Customers

You may also want to know
CSL's Sales Growth Rates CSL's Pe Price to earnings ratio CSL's Receivables Turnover Ratio CSL's Stock Quote
CSL's Net Income Growth Rates CSL's Ps Price to Sales ratio CSL's Sales per Employee CSL's Asset Turnover Ratio
CSL's Net Margin CSL's Pb Price to Book ratio CSL's Financial Strength Ratios CSL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.